aluates Reports

$ 0.0

Automative

Global Nanomedicine and Nanobiotechnology Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-34P12696

Global Nanomedicine and Nanobiotechnology Market Research Report 2023

BUY CHAPTERS

Global Nanomedicine and Nanobiotechnology Market Research Report 2025

Code: QYRE-Auto-34P12696

Report

June 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

GE Healthcare

Johnson & Johnson

Merck

Pfizer Inc

CombiMatrix

Celgene

Mallinckrodt plc

Sigma-Tau Pharmaceuticals

Teva Pharmaceutical

Nanosphere

UCB SA

Nanomedicine and Nanobiotechnology Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Nanomedicine and Nanobiotechnology Market

The global market for Nanomedicine and Nanobiotechnology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Nanomedicine and Nanobiotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicine and Nanobiotechnology.

The Nanomedicine and Nanobiotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanomedicine and Nanobiotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanomedicine and Nanobiotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanomedicine and Nanobiotechnology Market Report

Report Metric	Details
Report Name	Nanomedicine and Nanobiotechnology Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Nanoparticles Nanoshells Nanotubes Nanodevices Others
Segment by Application	Hospitals Clinics Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt, Sigma-Tau Pharmaceuticals, Teva Pharmaceutical, Nanosphere, UCB SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanomedicine and Nanobiotechnology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nanomedicine and Nanobiotechnology Market report?

Ans: The main players in the Nanomedicine and Nanobiotechnology Market are Abbott, GE Healthcare, Johnson & Johnson, Merck, Pfizer, CombiMatrix, Celgene, Mallinckrodt, Sigma-Tau Pharmaceuticals, Teva Pharmaceutical, Nanosphere, UCB SA

What are the Application segmentation covered in the Nanomedicine and Nanobiotechnology Market report?

Ans: The Applications covered in the Nanomedicine and Nanobiotechnology Market report are Hospitals, Clinics, Research Institute

What are the Type segmentation covered in the Nanomedicine and Nanobiotechnology Market report?

Ans: The Types covered in the Nanomedicine and Nanobiotechnology Market report are Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Others

Recommended Reports

Medical Biomaterials

Medical Devices Tech

Healthcare Digitalization

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanomedicine and Nanobiotechnology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nanoparticles

1.2.3 Nanoshells

1.2.4 Nanotubes

1.2.5 Nanodevices

1.2.6 Others

1.3 Market by Application

1.3.1 Global Nanomedicine and Nanobiotechnology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanomedicine and Nanobiotechnology Market Perspective (2020-2031)

2.2 Global Nanomedicine and Nanobiotechnology Growth Trends by Region

2.2.1 Global Nanomedicine and Nanobiotechnology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanomedicine and Nanobiotechnology Historic Market Size by Region (2020-2025)

2.2.3 Nanomedicine and Nanobiotechnology Forecasted Market Size by Region (2026-2031)

2.3 Nanomedicine and Nanobiotechnology Market Dynamics

2.3.1 Nanomedicine and Nanobiotechnology Industry Trends

2.3.2 Nanomedicine and Nanobiotechnology Market Drivers

2.3.3 Nanomedicine and Nanobiotechnology Market Challenges

2.3.4 Nanomedicine and Nanobiotechnology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanomedicine and Nanobiotechnology Players by Revenue

3.1.1 Global Top Nanomedicine and Nanobiotechnology Players by Revenue (2020-2025)

3.1.2 Global Nanomedicine and Nanobiotechnology Revenue Market Share by Players (2020-2025)

3.2 Global Nanomedicine and Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanomedicine and Nanobiotechnology Revenue

3.4 Global Nanomedicine and Nanobiotechnology Market Concentration Ratio

3.4.1 Global Nanomedicine and Nanobiotechnology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine and Nanobiotechnology Revenue in 2024

3.5 Global Key Players of Nanomedicine and Nanobiotechnology Head office and Area Served

3.6 Global Key Players of Nanomedicine and Nanobiotechnology, Product and Application

3.7 Global Key Players of Nanomedicine and Nanobiotechnology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanomedicine and Nanobiotechnology Breakdown Data by Type

4.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Type (2020-2025)

4.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Type (2026-2031)

5 Nanomedicine and Nanobiotechnology Breakdown Data by Application

5.1 Global Nanomedicine and Nanobiotechnology Historic Market Size by Application (2020-2025)

5.2 Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanomedicine and Nanobiotechnology Market Size (2020-2031)

6.2 North America Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025)

6.4 North America Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanomedicine and Nanobiotechnology Market Size (2020-2031)

7.2 Europe Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025)

7.4 Europe Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size (2020-2031)

8.2 Asia-Pacific Nanomedicine and Nanobiotechnology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanomedicine and Nanobiotechnology Market Size (2020-2031)

9.2 Latin America Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025)

9.4 Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size (2020-2031)

10.2 Middle East & Africa Nanomedicine and Nanobiotechnology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Nanomedicine and Nanobiotechnology Introduction

11.1.4 Abbott Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Nanomedicine and Nanobiotechnology Introduction

11.2.4 GE Healthcare Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Nanomedicine and Nanobiotechnology Introduction

11.3.4 Johnson & Johnson Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Nanomedicine and Nanobiotechnology Introduction

11.4.4 Merck Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Nanomedicine and Nanobiotechnology Introduction

11.5.4 Pfizer Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 CombiMatrix

11.6.1 CombiMatrix Company Details

11.6.2 CombiMatrix Business Overview

11.6.3 CombiMatrix Nanomedicine and Nanobiotechnology Introduction

11.6.4 CombiMatrix Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.6.5 CombiMatrix Recent Development

11.7 Celgene

11.7.1 Celgene Company Details

11.7.2 Celgene Business Overview

11.7.3 Celgene Nanomedicine and Nanobiotechnology Introduction

11.7.4 Celgene Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.7.5 Celgene Recent Development

11.8 Mallinckrodt

11.8.1 Mallinckrodt Company Details

11.8.2 Mallinckrodt Business Overview

11.8.3 Mallinckrodt Nanomedicine and Nanobiotechnology Introduction

11.8.4 Mallinckrodt Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.8.5 Mallinckrodt Recent Development

11.9 Sigma-Tau Pharmaceuticals

11.9.1 Sigma-Tau Pharmaceuticals Company Details

11.9.2 Sigma-Tau Pharmaceuticals Business Overview

11.9.3 Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Introduction

11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.9.5 Sigma-Tau Pharmaceuticals Recent Development

11.10 Teva Pharmaceutical

11.10.1 Teva Pharmaceutical Company Details

11.10.2 Teva Pharmaceutical Business Overview

11.10.3 Teva Pharmaceutical Nanomedicine and Nanobiotechnology Introduction

11.10.4 Teva Pharmaceutical Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.10.5 Teva Pharmaceutical Recent Development

11.11 Nanosphere

11.11.1 Nanosphere Company Details

11.11.2 Nanosphere Business Overview

11.11.3 Nanosphere Nanomedicine and Nanobiotechnology Introduction

11.11.4 Nanosphere Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.11.5 Nanosphere Recent Development

11.12 UCB SA

11.12.1 UCB SA Company Details

11.12.2 UCB SA Business Overview

11.12.3 UCB SA Nanomedicine and Nanobiotechnology Introduction

11.12.4 UCB SA Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025)

11.12.5 UCB SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

GE Healthcare

Johnson & Johnson

Merck

Pfizer Inc

CombiMatrix

Celgene

Mallinckrodt plc

Sigma-Tau Pharmaceuticals

Teva Pharmaceutical

Nanosphere

UCB SA

List of Tables

Table 1. Global Nanomedicine and Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nanoparticles

Table 3. Key Players of Nanoshells

Table 4. Key Players of Nanotubes

Table 5. Key Players of Nanodevices

Table 6. Key Players of Others

Table 7. Global Nanomedicine and Nanobiotechnology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nanomedicine and Nanobiotechnology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nanomedicine and Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nanomedicine and Nanobiotechnology Market Share by Region (2020-2025)

Table 11. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nanomedicine and Nanobiotechnology Market Share by Region (2026-2031)

Table 13. Nanomedicine and Nanobiotechnology Market Trends

Table 14. Nanomedicine and Nanobiotechnology Market Drivers

Table 15. Nanomedicine and Nanobiotechnology Market Challenges

Table 16. Nanomedicine and Nanobiotechnology Market Restraints

Table 17. Global Nanomedicine and Nanobiotechnology Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nanomedicine and Nanobiotechnology Market Share by Players (2020-2025)

Table 19. Global Top Nanomedicine and Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine and Nanobiotechnology as of 2024)

Table 20. Ranking of Global Top Nanomedicine and Nanobiotechnology Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nanomedicine and Nanobiotechnology Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nanomedicine and Nanobiotechnology, Headquarters and Area Served

Table 23. Global Key Players of Nanomedicine and Nanobiotechnology, Product and Application

Table 24. Global Key Players of Nanomedicine and Nanobiotechnology, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nanomedicine and Nanobiotechnology Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Type (2020-2025)

Table 28. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Type (2026-2031)

Table 30. Global Nanomedicine and Nanobiotechnology Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Application (2020-2025)

Table 32. Global Nanomedicine and Nanobiotechnology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Nanomedicine and Nanobiotechnology Revenue Market Share by Application (2026-2031)

Table 34. North America Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbott Company Details

Table 50. Abbott Business Overview

Table 51. Abbott Nanomedicine and Nanobiotechnology Product

Table 52. Abbott Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 53. Abbott Recent Development

Table 54. GE Healthcare Company Details

Table 55. GE Healthcare Business Overview

Table 56. GE Healthcare Nanomedicine and Nanobiotechnology Product

Table 57. GE Healthcare Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 58. GE Healthcare Recent Development

Table 59. Johnson & Johnson Company Details

Table 60. Johnson & Johnson Business Overview

Table 61. Johnson & Johnson Nanomedicine and Nanobiotechnology Product

Table 62. Johnson & Johnson Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 63. Johnson & Johnson Recent Development

Table 64. Merck Company Details

Table 65. Merck Business Overview

Table 66. Merck Nanomedicine and Nanobiotechnology Product

Table 67. Merck Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 68. Merck Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Nanomedicine and Nanobiotechnology Product

Table 72. Pfizer Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 73. Pfizer Recent Development

Table 74. CombiMatrix Company Details

Table 75. CombiMatrix Business Overview

Table 76. CombiMatrix Nanomedicine and Nanobiotechnology Product

Table 77. CombiMatrix Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 78. CombiMatrix Recent Development

Table 79. Celgene Company Details

Table 80. Celgene Business Overview

Table 81. Celgene Nanomedicine and Nanobiotechnology Product

Table 82. Celgene Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 83. Celgene Recent Development

Table 84. Mallinckrodt Company Details

Table 85. Mallinckrodt Business Overview

Table 86. Mallinckrodt Nanomedicine and Nanobiotechnology Product

Table 87. Mallinckrodt Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 88. Mallinckrodt Recent Development

Table 89. Sigma-Tau Pharmaceuticals Company Details

Table 90. Sigma-Tau Pharmaceuticals Business Overview

Table 91. Sigma-Tau Pharmaceuticals Nanomedicine and Nanobiotechnology Product

Table 92. Sigma-Tau Pharmaceuticals Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 93. Sigma-Tau Pharmaceuticals Recent Development

Table 94. Teva Pharmaceutical Company Details

Table 95. Teva Pharmaceutical Business Overview

Table 96. Teva Pharmaceutical Nanomedicine and Nanobiotechnology Product

Table 97. Teva Pharmaceutical Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 98. Teva Pharmaceutical Recent Development

Table 99. Nanosphere Company Details

Table 100. Nanosphere Business Overview

Table 101. Nanosphere Nanomedicine and Nanobiotechnology Product

Table 102. Nanosphere Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 103. Nanosphere Recent Development

Table 104. UCB SA Company Details

Table 105. UCB SA Business Overview

Table 106. UCB SA Nanomedicine and Nanobiotechnology Product

Table 107. UCB SA Revenue in Nanomedicine and Nanobiotechnology Business (2020-2025) & (US$ Million)

Table 108. UCB SA Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

Table 112. Authors List of This Report

List of Figures

Figure 1. Nanomedicine and Nanobiotechnology Picture

Figure 2. Global Nanomedicine and Nanobiotechnology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanomedicine and Nanobiotechnology Market Share by Type: 2024 VS 2031

Figure 4. Nanoparticles Features

Figure 5. Nanoshells Features

Figure 6. Nanotubes Features

Figure 7. Nanodevices Features

Figure 8. Others Features

Figure 9. Global Nanomedicine and Nanobiotechnology Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Nanomedicine and Nanobiotechnology Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Research Institute Case Studies

Figure 14. Nanomedicine and Nanobiotechnology Report Years Considered

Figure 15. Global Nanomedicine and Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nanomedicine and Nanobiotechnology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nanomedicine and Nanobiotechnology Market Share by Region: 2024 VS 2031

Figure 18. Global Nanomedicine and Nanobiotechnology Market Share by Players in 2024

Figure 19. Global Top Nanomedicine and Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine and Nanobiotechnology as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nanomedicine and Nanobiotechnology Revenue in 2024

Figure 21. North America Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nanomedicine and Nanobiotechnology Market Share by Country (2020-2031)

Figure 23. United States Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nanomedicine and Nanobiotechnology Market Share by Country (2020-2031)

Figure 27. Germany Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nanomedicine and Nanobiotechnology Market Share by Region (2020-2031)

Figure 35. China Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nanomedicine and Nanobiotechnology Market Share by Country (2020-2031)

Figure 43. Mexico Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nanomedicine and Nanobiotechnology Market Share by Country (2020-2031)

Figure 47. Turkey Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nanomedicine and Nanobiotechnology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbott Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 51. GE Healthcare Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 52. Johnson & Johnson Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 55. CombiMatrix Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 56. Celgene Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 57. Mallinckrodt Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 58. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 59. Teva Pharmaceutical Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 60. Nanosphere Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 61. UCB SA Revenue Growth Rate in Nanomedicine and Nanobiotechnology Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nanotechnology Medical Devices Market Research Report 2025

Gold Nanoparticles in Biology and Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nano Healthcare Technology for Medical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nanotechnology in Dental Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanorobotics in Medicine Market Research Report 2025

Innovative Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genomic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digitalization in the Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare IoT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

0 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Additive Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biomedical Imaging Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mobile Health Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Smart Healthcare Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Additive Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nano Medical Device Market Research Report 2025

Biomedical Imaging Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Patient Financing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions